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Abstract
Background:  There is a paucity of clinical studies focused specifically on intracerebral
haemorrhages of subcortical topography, a subject matter of interest to clinicians involved in stroke
management. This single centre, retrospective study was conducted with the following objectives:
a) to describe the aetiological, clinical and prognostic characteristics of patients with thalamic
haemorrhage as compared with that of patients with internal capsule-basal ganglia haemorrhage,
and b) to identify predictors of in-hospital mortality in patients with thalamic haemorrhage.
Methods: Forty-seven patients with thalamic haemorrhage were included in the "Sagrat Cor
Hospital of Barcelona Stroke Registry" during a period of 17 years. Data from stroke patients are
entered in the stroke registry following a standardized protocol with 161 items regarding
demographics, risk factors, clinical features, laboratory and neuroimaging data, complications and
outcome. The region of the intracranial haemorrhage was identified on computerized tomographic
(CT) scans and/or magnetic resonance imaging (MRI) of the brain.
Results: Thalamic haemorrhage accounted for 1.4% of all cases of stroke (n = 3420) and 13% of
intracerebral haemorrhage (n  = 364). Hypertension (53.2%), vascular malformations (6.4%),
haematological conditions (4.3%) and anticoagulation (2.1%) were the main causes of thalamic
haemorrhage. In-hospital mortality was 19% (n = 9). Sensory deficit, speech disturbances and
lacunar syndrome were significantly associated with thalamic haemorrhage, whereas altered
consciousness (odds ratio [OR] = 39.56), intraventricular involvement (OR = 24.74) and age (OR
= 1.23), were independent predictors of in-hospital mortality.
Conclusion: One in 8 patients with acute intracerebral haemorrhage had a thalamic hematoma.
Altered consciousness, intraventricular extension of the hematoma and advanced age were
determinants of a poor early outcome.
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Background
Most studies of primary intracerebral haemorrhages are
focused on the global assessment of patients with haem-
orrhagic stroke independent of the different topography
of lesions [1,2]. It has recently been shown that the clini-
cal spectrum, prognosis and early mortality of patients
with primary intracerebral haemorrhage are reasonably
dependent on the site of bleeding [3]. On the other hand,
thalamic haemorrhages and basal ganglia-internal capsule
haemorrhages are a group of supratentorial cerebral
haemorrhages of subcortical topography, with clinical
characteristics that are clearly different from those of the
remaining cases of lobar or brainstem haemorrhages
[1,2]. However, the differential clinical profile between
subcortical cerebral haemorrhages of isolated thalamic
topography and haemorrhages involving the basal ganglia
and the internal capsule is poorly defined. Moreover, pre-
dictors of in-hospital mortality in patients with isolated
thalamic haemorrhage are not clearly established proba-
bly because in clinical series collected from hospital-based
stroke registries, separate analysis of thalamic haemor-
rhage as an individual clinical entity is rarely performed.
This aim of this study was to describe the aetiological,
clinical and prognostic characteristics of patients with tha-
lamic haemorrhage as compared with that of patients
with basal ganglia-internal capsule haemorrhage collected
from a prospective hospital-based stroke registry. A sec-
ond objective was to identify predictors of in-hospital
mortality in patients with thalamic haemorrhage.
Methods
The database of the "Sagrat Cor Hospital of Barcelona
Stroke Registry" with data of 3420 acute stroke patients
was searched for those with a diagnosis of intracerebral
haemorrhage who were admitted consecutively to the
Department of Neurology of the Sagrat Cor Hospital (an
acute-care 350-bed teaching hospital in the city of Barce-
lona) between January 1986 and December 2002. Details
of this on-going hospital-based stroke registry have been
reported in previous studies [4,5]. Data from stroke
patients are entered following a standardized protocol
with 161 items regarding demographics, risk factors, clin-
ical features, laboratory and neuroimaging data, compli-
cations and outcome. Subtypes of stroke were classified
according to the Cerebrovascular Study Group of the
Spanish Neurological Society [6], which is similar to the
National Institute of Neurological Disorders and Stroke
Classification [7]. Definitions of cerebrovascular risk fac-
tors have been used by our group in previous studies [3-
5].
For the purpose of this study, primary intracerebral haem-
orrhages diagnosed in 364 patients were collected. The
region of the intracranial haemorrhage was identified on
computerized tomographic (CT) scans and/or magnetic
resonance imaging (MRI) of the brain. The volume of hae-
matomas was measured. Haematomas were divided into
small and large using a diameter of 30 mm. Topographies
included the thalamus in 47 patients, internal capsule and
basal ganglia in 77, cerebral lobes in 140, cerebellum in
27, brainstem in 18, primary intraventricular haemor-
rhage in 11 and multiple topographic involvement (when
more than one of the aforementioned topographies was
affected by the haemorrhage and the size of the hae-
matoma was > 30 mm) in 44. The objective of this clinical
study was to assess differential features in aetiology, risk
factors, clinical findings and early outcome between the
cohorts of patients with thalamic haemorrhage (n = 47)
and internal capsule-basal ganglia haemorrhage (n = 77).
Prior to conducting the study, approval was obtained
from the Ethical Committee of Clinical Research of the
hospital.
All patients were admitted to the hospital within 48 hours
of onset of symptoms. On admission, demographic char-
acteristics; salient features of clinical and neurological
examination and results of laboratory tests (blood cell
count, biochemical profile, serum electrolytes, urinalysis);
chest radiography; twelve-lead electrocardiography; and
brain CT and/or MRI were recorded. Angio-MRI was
obtained during hospitalisation in 17% of cases and arte-
rial digital subtraction angiography was performed in
16% of patients with thalamic haemorrhage in whom we
could not find any risk factor for haemorrhagic stroke.
Other investigations included echocardiography in 10.6%
of patients and lumbar puncture in 6.4%. Degree of clini-
cal disability at discharge from the hospital was evaluated
according to modified Rankin scale (mRS) [8], and causes
of death according to the criteria of Silver et al. [9].
Statistical analysis
Demographic characteristics, risk factors, clinical events
and outcome of patients with thalamic haemorrhage and
those with internal capsule-basal ganglia haemorrhage
were compared using the Student's t-test or the Mann-
Whitney U test for continuous variables and the chi-
square (χ2) test (with Yate's correction when necessary)
for categorical variables. Variables were subjected to mul-
tivariate analysis with a logistic regression procedure and
forward stepwise selection if P < 0.10 after univariate test-
ing. The effect of variables on the presence of thalamic
haemorrhage and fatal outcome was studied in two mul-
tiple regression models based on demographic, vascular
risk factors, and clinical and neuroimaging variables, in
which thalamic haemorrhage and in-hospital mortality
were the dependent variables, respectively. Statistical sig-
nificance was set at P < 0.05.BMC Neurology 2007, 7:32 http://www.biomedcentral.com/1471-2377/7/32
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Results
Thalamic haemorrhage accounted for 1.4% of all cases of
stroke (n = 3420) and 13% of intracerebral haemorrhage
(n = 364). There were 27 men and 20 women with a mean
(SD) age of 71.6 (10.9) years. The following vascular risk
factors in a decreasing order of frequency were observed:
history of hypertension (61.7%), diabetes mellitus (17%)
and alcohol abuse (> 80 g/day) (12.8%). Sudden onset of
neurological deficit was recorded in 74.5% of cases. Motor
deficit occurred in 78.7% of cases, sensory deficit in
70.2%, altered consciousness in 31.9%, headache in
29.8%, nausea or vomiting in 27.7%, speech disturbances
(dysarthria, aphasia) in 21.3% and oculomotor and visual
disturbances in 21.3% (upward gaze palsy with miotic
unreactive pupils, skew ocular deviation). Abnormal
involuntary movements were present in only 2 patients.
On the other hand, 4 patients had a lacunar syndrome
(pure sensory stroke 3, sensorimotor stroke 1). The topog-
raphy of thalamic lesion [10] was anterior in 6% of cases,
posteromedial in 24%, posterolateral in 48%, dorsal in
2% and affected all thalamic vascular territories in 20%.
Intraventricular involvement was present in 42.6% of
patients.
Hypertension (53.2%), vascular anomaly (6.4%), haema-
tological conditions (4.3%) and anticoagulation (2.1%)
were the main causes of thalamic haemorrhage. The aeti-
ology of thalamic bleeding was not identified in 34% of
patients. One patient had surgical intervention (ventricu-
lar drainage). Median duration of hospital stay was 20
days (25th–75th percentile, 11–30 days). At the time of
hospital discharge, 1 patient (2.1%) was symptom free
(mRS grade 0). Of the remaining 37 patients, 11 had
moderate disability (mRS grade 3), 15 moderately severe
disability (mRS grade 4) and 11 severe disability (mRS
grade 5). Significant altered memory function was present
in 1 patient at hospital discharge. A total of 9 patients died
(in-hospital mortality rate 19.1%). The median time of
death was 11 days (25th–75th percentile, 6–13.5 days).
Cumulative in-hospital mortality in relation to length of
hospital stay showed that 33% of all deaths had occurred
on day 7, 88.5% on day 14, and 100% on day 90. Causes
of death included cerebral herniation in 4 patients, pneu-
monia in 2, sepsis in 2 and unknown cause in 1.
When the groups of patients with thalamic haemorrhage
with favourable and unfavourable outcome were com-
pared (Table 1), advanced age, altered consciousness,
neurological complications and intraventricular exten-
sion of the haemorrhage were significantly more frequent
in patients who died. In the multivariate analysis,
advanced age, altered consciousness and intraventricular
involvement were independent variables significantly
associated with in-hospital death (Table 2).
The characteristics of patients with thalamic haemorrhage
in comparison with the cohort of 77 patients with internal
capsule-basal ganglia haemorrhage are shown in Table 3.
History of chronic liver disease, sensory symptoms, nau-
sea and/or vomiting and ataxia was significantly more fre-
quent in patients with thalamic haemorrhage, whereas
speech disturbances (dysarthria, aphasia) and clinical
presentation as a lacunar syndrome were significantly
more common among patients with internal capsule-
basal ganglia haemorrhage. In the multivariate analysis
sensory deficit (odds ratio [OR] = 2.33, 95% confidence
interval [CI] 1.10–4.84; P = 0.040), speech disturbances
(OR = 0.34, 95% CI 0.16–0.86; P = 0.015) and lacunar
syndrome (OR = 0.26, 95% CI 0.15–0.89; P = 0.026) were
independent predictors of isolated thalamic haemor-
rhage.
Discussion
Data regarding the frequency of isolated thalamic haem-
orrhage in the different hospital-based stroke registries are
scarce, the present results show that thalamic haemato-
mas is a subgroup of haemorrhagic stroke that accounted
for 1.4% of all cases of stroke and 13% of intracerebral
haemorrhages. The prevalence of thalamic haemorrhage
in different series of primary intracerebral haemorrhage
vary widely from 6% in the series of Juvela et al. [11] to
15.7% in the series of Tatu et al. [12]. In a subsample of
390 with haemorrhagic stroke reported by Kumral et al.
[13], thalamic haemorrhage was diagnosed in 100
patients (25.6%).
Results of the present study show that patients with tha-
lamic haemorrhage and patients with internal capsule-
basal ganglia haemorrhage presented different clinical
profiles, with sensory disturbances being significantly
more frequent and speech disorders and lacunar syn-
drome being significantly less frequent in patients with
thalamic haematoma. Prominent sensory loss, either
anaesthesia or hypaesthesia affecting face, limbs and
trunk, generally for all sensory modalities was found in
70.2% of patients, which is consistent with classical
reports showing the predominance of sensory deficit as a
cardinal feature of thalamic haemorrhage especially when
the ventroposterolateral nucleus is affected [1,14,15].
Speech disturbances are less frequent in patients with tha-
lamic haemorrhage (21%) as compared with those with
internal capsule-basal ganglia haemorrhage (44.2%).
Dysarthria and different types of aphasia was explained in
thalamic haemorrhage as a disruption of any circuit
(arranged as frontal rostrocaudal/thalamic mediolater-
ally) leading to dysfunction [1,2]. However, interruption
of the corticolingual pathways in the internal capsule may
explain the higher frequency of speech disturbancesBMC Neurology 2007, 7:32 http://www.biomedcentral.com/1471-2377/7/32
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Table 2: Variables associated with in-hospital death in patients with thalamic haemorrhage
Variable β SE (β) Odds ratio (95% CI) p
Model based on demographics, vascular risk factors and clinical variables*
Altered consciousness 3.223 1.120 25.10 (2.8–225.3) 0.004
Age 0.160 0.069 1.17 (1.03–1.34) 0.020
Model based on demographics, vascular risk factors, clinical features and neuroimaging variables†
Altered consciousness 3.678 1.471 39.59 (2.51–707.37) 0.012
Intraventricular involvement 3.209 1.600 24.74 (1.07–569.60) 0.045
Age 0.210 0.103 1.23 (1.01–1.51) 0.042
*β = -15.114; SE (β) = 5.651; goodness-of-fit χ2 = 1.265; df = 7; P = 0.989; area under the ROC curve = 0.924; sensitivity 60%; specificity 71%; positive 
predictive value 56%; negative predictive value 74%; correct classification 66.9%.
†β = -21.386; SE (β) = 9.304; goodness-of-fit χ2 = 1.604 ; df = 7 ; P = 0.978; area under the ROC curve = 0.949; sensitivity 78%; specificity 87%; 
positive predictive value 57%; negative predictive value 94%; correct classification 85.1%.
Table 1: Results of univariate analysis in 47 patients with thalamic haemorrhage according to early outcome
Data Alive (n = 38) Dead (n = 9) P value
Age, years, mean (SD) 69.5 (10.9) 80.2 (5.2) 0.002
Sex
Male 24 (88.9) 3 (11.1) 0.106
Female 14 (70) 6 (30) 0.371
Valvular heart disease
Absent 38 (100) 8 (17.4) 0.191
Present 0 1 (100)
Transient ischaemic attack
Absent 38 (100) 8 (17.4) 0.191
Present 0 1 (100)
Obesity
Absent 36 (83.7) 7 (16.7) 0.160
Present 2 (50) 1 (50)
Hyperlipidemia
Absent 34 (85) 6 (15) 0.117
Present 4 (57.1) 3 (42.9)
Nausea, vomiting
Absent 29 (85.3) 5 (14.7) 0.198
Present 9 (69.2) 4 (30.8)
Altered consciousness
Absent 30 (93.8) 2 (6.3) 0.002
Present 8 (53.3) 7 (46.7)
Sensory deficit
Absent 9 (64.3) 5 (35.7) 0.074
Present 29 (87.9) 4 (12.1)
Lacunar syndrome
Absent 34 (79.1) 9 (20.9) 0.724
Present 4 (100) 0
Intraventricular involvement
Absent 26 (96.3) 1 (3.7) 0.003
Present 12 (60) 8 (40.5)
Neurological complications
Absent 36 (90) 4 (10) 0.001
Present 2 (28.6) 5 (71.4)
Respiratory events
Absent 33 (84.6) 6 (15.4) 0.167
Present 5 (62.5) 3 (37.5)
Data are n (%) unless otherwise stated.BMC Neurology 2007, 7:32 http://www.biomedcentral.com/1471-2377/7/32
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(mainly dysarthria) in internal capsule-basal ganglia
haemorrhages [16,17].
Clinical presentation of thalamic haemorrhage in the
form of a lacunar syndrome is very rare, and was docu-
mented in only 4 patients (8.5%), 3 of whom presenting
with a pure sensory stroke and 1 a sensorimotor syn-
drome. This finding is in accordance with a recent study of
our group [18] and with data reported in the literature
showing that pure sensory stroke is classically associated
with a lacunar thalamic infarction [19].
Whereas none of the patients in the series of Kumral et al.
[13] presented with pure sensorimotor stroke, a lacunar
syndrome was observed in 23.4% of our patients with
internal capsule-basal ganglia haemorrhage, mainly in the
form of a pure motor stroke or sensorimotor stroke. These
findings are consistent with the study of Weisberg and
Wall (20) who reported pure motor hemiparesis in 7 out
of 10 patients as well as with other reports indicating that
a small haematoma of subcortical topography in the inter-
nal capsule but also in the basal ganglia may cause a lacu-
nar syndrome [21].
Thalamic haemorrhage is a severe clinical condition with
an in-hospital mortality rate, in the present study, of 19%,
and only one patient (2.1%) was symptom-free at dis-
charge. The mortality rate of thalamic haemorrhage was
12% after 6 ± 6 days after stroke and 17.3% within 6
months in the series of Mori et al. [22]. In the series of
Chung et al. [23], the case fatality was 37% at the time of
discharge. On the other hand, the mortality rate of tha-
lamic haemorrhage is generally lower than that of brain-
stem haemorrhages or cerebral haemorrhages of multiple
topographies, which show a very high in-hospital mortal-
ity rate usually greater than 40% [3]. The mortality rate in
patients with thalamic haemorrhage, however, is higher
than that of patient with capsular stroke [3,16,17]. Altered
consciousness, intraventricular hemorrhage and advanced
age were independent predictors of in-hospital mortality
in patients with thalamic haematoma.
The initial level of consciousness was always found to be
a predictor of mortality in the differents series [3,11-15].
Previous studies reported that initially comatose or stu-
purous patients had the poorest chance of survival [1,2].
Intraventricular haemorrhage has been found to be a pre-
Table 3: Differences between patients with thalamic haemorrhage and patients with internal capsule-basal ganglia haemorrhage
Data Thalamic haemorrhage Internal capsule-basal ganglia haemorrhage P value
Total patients 47 77
Sex, male 27 (57.4) 50 (64.9) 0.259
Age, years, mean (SD) 71.6 (10.9) 72.2 (12.2) 0.661
Vascular risk factors
Hypertension 29 (61.7) 57 (74) 0.107
Diabetes mellitus 8 (17) 9 (11.7) 0.282
Dyslipemia 7 (14.9) 10 (13) 0.481
Atrial fibrillation 5 (10.6) 11 (14.3) 0.384
Ischaemic heart disease 3 (6.4) 5 (6.5) 0.646
Cigarette smoking (> 20/day) 3 (6.4) 8 (10.4) 0.339
Chronic liver disease 5 (10.6) 0 0.007
Clinical findings
Sudden onset (min) 35 (74.5) 48 (52.3) 0.115
Limb weakness 37 (78.7) 67 (87) 0.167
Sensory symptoms 33 (70.2) 38 (49.4) 0.018
Altered consciousness 15 (31.9) 23 (29.9) 0.482
Headache 14 (29.8) 18 (23.4) 0.279
Nausea, vomiting 13 (27.7) 10 (13) 0.037
Speech disturbances (dysarthria, aphasia) 10 (21.3) 34 (44.2) 0.008
Ataxia 4 (8.5) 0 0.019
Lacunar syndrome 4 (8.5) 18 (23.4) 0.036
Ventricular involvement 20 (42.6) 12 (15.6) 0.001
Outcome
In-hospital mortality 9 (19.1) 13 (16.9) 0.464
Respiratory complications 8 (17) 8 (10.4) 0.212
Urinary complications 8 (17) 7 (9.1) 0.152
Infectious complications 16 (34) 17 (22.1) 0.106
Symptom-free at discharge 1 (2.1) 6 (7.8) 0.180
Data are n (%) unless otherwise stated.BMC Neurology 2007, 7:32 http://www.biomedcentral.com/1471-2377/7/32
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dictor of in-hospital mortality in some studies [13,24,25]
but not in others [11,22,26] and one study has even sug-
gested that intraventricular bleeding is associated with
improved outcome in thalamic haemorrhage [27]. How-
ever, our results shows that stroke-related deaths occurred
in 40.5% of intraventricular haemorrhage cases and agree
with that of the Steinke et al. [25] who found that in-hos-
pital mortality occurred in 52% of thalamic haematomas
with ventricular extension and that intraventricular exten-
sion is an powerful independent predictor of mortality
(Table 4). Death increased with age and agree with the
study of Mori et al. [22]. In the study of Daverat el al. [28],
age was the most important predictor of death and func-
tional outcome after spontaneous intracerebral haemor-
rhage.
Early expansion of cerebral haematoma of any topogra-
phy is an important determinant of in-hospital mortality
[29,30]. Recent studies have shown that ultra-early hae-
mostatic therapy with recombinant activated factor VII
(rFVIIa) within four hours after the onset of intracerebral
hemorrhage limits the growth of the haematoma, reduces
mortality, and improves functional outcomes [31]. These
preliminary findings will probably determine a change in
the management of patients with acute intracerebral
haemorrhage, in which ultra-early haemostatic therapy, –
similar to the efficacy of early thrombolytic therapy in cer-
ebral infarction –, followed by careful monitorization in
specialised stroke units could be of paramount impor-
tance in the care of patients with intracerebral haemor-
rhage [32].
Conclusion
Approximately one in every 8 patients with acute intracer-
ebral haemorrhage had a thalamic haematoma. Patients
with isolated thalamic haemorrhage show a differential
clinical profile than patients with internal capsule-basal
ganglia haemorrhage. Altered consciousness, intraven-
tricular involvement and advanced age were independent
predictors of in-hospital mortality.
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Table 4: Thalamic haemorrhage. Series reported in the literature
Author, year [reference] Patients Type of study Frequency intracerebral 
haemorrhages (%)
Ventricular 
Extension (%)
Ventricular extension as 
predictor of in-hospital death
In-hospital 
mortality (%)
Walshe, 1977 [14] 18 Clinical series 66
Barraquer-Bordas, 1981 [15] 23 Clinical series 50 39
Kwak, 1983 [26] 29 Clinical series No
Weisberg, 1986 [24] 50 Clinical series 38 Yes 38
Steinke, 1992 [25] 44 Stroke data bank 47.7 Yes 31.8
Kumral, 1995 [13] 100 Stroke data bank 25.6 57 Yes 25
Mori, 1995 [22] 104 Clinical series 44 No 17.3 (6 months)
Lampl, 1995 [27]* 52 Clinical series 63.5 No 36.6 (6 moths)
Chung, 1996 [23] 175 Clinical series † 37
Shah, 2005 [30] 53 Clinical series 66.6 No 15.7
Present series, 2007 47 Hospital-based stroke registry 13 42.6 Yes 19.1
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